This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan
by Zacks Equity Research
MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management experts for patients starting in 2026.
Berkshire Boosts Mitsubishi Stake, Increases Investment in Japan
by Tanuka De
Berkshire lifts its Mitsubishi stake to 10.23%, deepening its Japan bet with rising dividends, low-cost debt and governance gains.
Why Berkshire Hathaway is Expanding Its Investments in Japan?
by Tanuka De
BRK.B deepens its Japan bets with $23.5B stakes, yen bonds, and rising dividends fueling long-term growth.
MetLife Q2 Earnings Lag Estimates on Soft MetLife Holdings Unit
by Zacks Equity Research
MET misses on Q2 earnings as MetLife Holdings drags results. However, gains in EMEA and Latin America provide some relief.
Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MetLife (MET) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -7.76% and -2.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Will These 4 Insurance Stocks Deliver a Q2 Earnings Surprise?
by Kaibalya Pravo Dey
MFC, MET, AIG and ROOT gear up for Q2 results as insurance tailwinds battle cost pressures and catastrophe risks.
MetLife to Report Q2 Earnings: What Do Key Estimates Say?
by Zacks Equity Research
MET's Q2 results are likely to reflect gains from group benefits and Latin America profits. However, higher costs may weigh on results.
Ahead of MetLife (MET) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of +2.35% and +19.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
by Zacks Equity Research
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Radian Hits 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
MetLife Teams Up With Sprout.ai to Advance Global Claims Automation
by Zacks Equity Research
MET taps Sprout.ai to speed up global claims processing, blending AI automation with human-centered service.
MetLife Broadens Upwise Reach Through Nayya and Workday Deal
by Zacks Equity Research
Taking Nayya's help, MET expands the reach of its Upwise platform by making it available via the Workday Marketplace. This is expected to boost uptake of Employee Benefit plans.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Is Assurant (AIZ) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is MetLife (MET) Up 4.1% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Radian Group Near 52-Week High: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
Zacks Industry Outlook Highlights MetLife, American International, Principal Financial, Everest and Assurant
by Zacks Equity Research
MetLife, American International, Principal Financial, Everest and Assurant have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancements and improving inflation are expected to aid multiline insurers like MET, AIG, PFG, EG and AIZ.
Top Analyst Reports for Oracle, IBM & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), IBM Corp. (IBM) and Merck & Co., Inc. (MRK), as well as a micro-cap stock Earth Science Tech, Inc. (ETST).
MetLife Q1 Earnings Lag Estimates on High Expenses, Soft Asia Unit
by Zacks Equity Research
MET's Q1 earnings were hurt by higher expenses, tax rate changes in Asia and weaker Latin America results, partly offset by strength in Group Benefits and EMEA segments.
MetLife (MET) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Lags Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -1.51% and 3.40%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?